Cataract prevalence and prevention in Europe: a literature review

DSpace Repository

Show simple item record

dc.contributor Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tuebingen, Tuebingen, Germany de_CH
dc.contributor.author Prokofyeva, Elena de_DE
dc.contributor.author Wegener, Alfred de_DE
dc.contributor.author Zrenner, Eberhart de_DE
dc.date.accessioned 2012-09-17 de_DE
dc.date.accessioned 2014-03-18T09:45:43Z
dc.date.available 2012-09-17 de_DE
dc.date.available 2014-03-18T09:45:43Z
dc.date.issued 2012 de_DE
dc.identifier.other 371006031 de_DE
dc.identifier.uri http://nbn-resolving.de/urn:nbn:de:bsz:21-opus-64163 de_DE
dc.identifier.uri http://hdl.handle.net/10900/46002
dc.description.abstract This literature review is aimed at the evaluation of the potential for cataract prevention in Europe. It was performed using Pub-MED with Mesh and free text terms. Studies included were: a) performed on a population of Caucasian origin at an age range of 40-95 years, b) cataract was clinically verified, c) drug record of prescriptions, their indication, a record of every diagnosis, dosage, and quantity of prescribed medicine were available, d) sample size >300, e) published between 1990 and 2009. The results of 29 articles were reviewed. Former (3.75 [2.26-6.21]) or current smoking (2.34 [1.07-5.15]), diabetes of duration >10 years (2.72 [1.72-4.28]), asthma or chronic bronchitis (2.04 [1.04-3.81]), and cardiovascular disease (1.96 [1.22-3.14]) increased the risk of cataract. Cataract was more common in patients taking chlorpromazine during >90 days with a dosage >300 mg, corticosteroids used >5 years (3.25 [1.39-7.58]) in a daily dose >1600 mg (1.69 [1.17-2.43]), a multivitamin/mineral formulation (2.00 [1.35-2.98]) or corticosteroids (2.12 [1.93-2.33]). Corticosteroid applied orally (3.25 [1.39-7.58]), parenteral (1.56 [1.34-1.82]) or inhalational (1.58 [1.46-1.71]) lead to cataract more frequently than those applied topically: nasal (1.33 [1.21-1.45]), ear (1.31 [1.19-1.45]), or skin (1.43 [1.36-1.50]). Outpatient cataract surgery was negatively associated with total cataract surgery costs, and chlorpromazine, corticosteroids, and multivitamin/mineral formation increase the risk of posterior sub-capsular cataract dependent on dose, treatment application, and duration. This review presented a comprehensive overview of specific and general cataract risk factors and an update on most recent experimental studies and randomized control trials directed at cataract prevention. en
dc.language.iso en de_DE
dc.publisher Universität Tübingen de_DE
dc.rights ubt-podno de_DE
dc.rights.uri http://tobias-lib.uni-tuebingen.de/doku/lic_ohne_pod.php?la=de de_DE
dc.rights.uri http://tobias-lib.uni-tuebingen.de/doku/lic_ohne_pod.php?la=en en
dc.subject.classification Grauer Star , Epidemiologie , Europa de_DE
dc.subject.ddc 610 de_DE
dc.subject.other Adverse effect , Cataract , Cataract surgery , Costs , Epidemiology , Europe , Medications , Prevention , Risk factors en
dc.title Cataract prevalence and prevention in Europe: a literature review en
dc.type ResearchPaper de_DE
utue.publikation.fachbereich Medizin de_DE
utue.publikation.fakultaet 4 Medizinische Fakultät de_DE
dcterms.DCMIType Text de_DE
utue.publikation.typ workingPaper de_DE
utue.opus.id 6416 de_DE
utue.publikation.source Acta Ophthalmol. 2012 Jun 20. doi: 10.1111/j.1755-3768.2012.02444.x. [Epub ahead of print] de_DE

Dateien:

This item appears in the following Collection(s)

Show simple item record